EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CLINICAL EVALUATION OF HAMMAM-i-YABIS IN SIMAN-E-MUFRIT (DYSLIPIDAEMIA); A CASE REPORT

Sajid Habib*, Abdul Nasir Ansari, Abdul Aziz, Mohd Mudassir

ABSTRACT

Disorders of lipoprotein metabolism are collectively referred to as “dyslipidemias”. Dyslipidemia are generally characterized by increased plasma level of cholesterol, triglycerides, or both variably accompanied by reduced level of HDL cholesterol. Incidence of hyperlipidaemia is higher among male than female. Management of dyslipidemia have been conducted from time to time and many effective drugs have been introduced in Allopathic medicine. In USM, Siman-e-Mufrit is a disease which occurs due to deposition of Barid Ratab madda that is Shaham and fall under the category of Amraz-e-Balghami., most of the diseases are caused by Maddah, either due to quantitative or qualitative imbalances in humours. Such diseases are referred to as “Maddi Amraz” and these arise due to abnormal change in the body humours. The most preferable and beneficial principle of treatment of such diseases, is the principle of “Istifragh” (evacuation). Hammam is the one of various ways through which Istifragh of abnormal humours can be brought about. Hammam has been described as the best way to carry out Istifragh as it result in Tanqiyah of all body humours simultaneously. Hammam like Riyazat and Dalk is the part of Asbab -e- ghairZaroriyah which means they are not essential for the existence of life but if they are performed they maintain the health. Hammam have three rooms having different temperament, the first room is Sard-Tar (BaridRatab), second is Garm - Tar ( HaarRatab ) and the third room is Garm -khushk( Haaryabis ). Instead of this the 4th room which is not included as the room of hammam is used for the changing clothes and for the relaxationsss. The bather enters the rooms successively till the third room or it can stop according to the need. It evacuates the superfluous matter or waste matter from the body in the form of sweat and vapors.

Keywords: Siman-e-Mufrit, Istifragh, Hammam, Asbab -e- ghairZaroriyah.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 January 2022 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: JANUARY ISSUE PUBLISHED

    JANUARY Issue has been successfully launched on 1 January 2022.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )